Oscar Ekpenyong

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Skeletal Muscle

Prostate Cancer

Liquid Chromatography Tandem Mass Spectrometry

Endoplasmic Reticulum

Top Venues

Pharmaceuticals (Basel, Switzerland)

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Mahua Sarkar, Yang Wang, Oscar Ekpenyong, Dong Liang, Huan Xie
Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology (2022)
Lu Turković, Luka Bočkor, Oscar Ekpenyong, Tajana Silovski, Mila Lovrić, Slaven Crnković, Biljana Nigović, Miranda Sertić
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Oscar Ekpenyong, Candace Cooper, Jing Ma, Naihsuan C Guy, Ashley N Payan, Fuqiang Ban, Artem Cherkasov, Marc B Cox, Dong Liang, Huan Xie
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)